Hans Clevers
Corporate Officer/Principal chez ROCHE HOLDING AG
Profil
Hans Clevers is the founder of Surrozen Operating, Inc. (founded in 2015) and Xilis, Inc. (founded in 2019).
He currently holds positions as the Director at F.
Hoffmann-La Roche Ltd.
since 2019, Head-Pharma Research & Early Development at Roche Holding AG since 2019, and Professor-Molecular Genetics at the University of Utrecht since 1989.
Previously, he worked as the Director at Genentech, Inc., Director at the American Association for Cancer Research from 2012 to 2015, Director-Royal Netherlands Academy at the Hubrecht Institute from 2002 to 2012, Research Director at the Princess Maxima Centre For Pediatric Oncology from 2015 to 2019, Venture Partner at LSP Management Group BV from 2001 to 2022, President at The Royal Netherlands Academy of Arts & Sciences from 2002 to 2015, President at The International Society for Stem Cell Research from 2017 to 2018, President at the International Society of Differentiation, Inc. from 2006 to 2008, and Chief Scientific Officer at the Hubrecht Organoid Technology Foundation from 2014 to 2020.
He obtained his graduate and doctorate degrees from the University of Utrecht.
Postes actifs de Hans Clevers
| Sociétés | Poste | Début |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 18/03/2022 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Director/Board Member | 05/03/2019 |
| University of Utrecht | Corporate Officer/Principal | 01/01/1989 |
Anciens postes connus de Hans Clevers
| Sociétés | Poste | Fin |
|---|---|---|
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Committee Member | 28/02/2022 |
| Hubrecht Organoid Technology Foundation | Corporate Officer/Principal | 01/01/2020 |
| Princess Maxima Centre For Pediatric Oncology | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| The International Society for Stem Cell Research | President | 01/01/2018 |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | President | 01/01/2015 |
Formation de Hans Clevers
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 12 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Finance |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Commercial Services |
| The International Society for Stem Cell Research | |
Hubrecht Institute
 Hubrecht Institute BiotechnologyHealth Technology The Hubrecht Institute is a research institute that focuses on fundamental, multidisciplinary research on healthy and diseased cells, tissues, and organisms. The location of the private company is in Utrecht, Netherlands. The institute encompasses 23 research groups dedicated to this mission. | Health Technology |
International Society of Differentiation, Inc.
 International Society of Differentiation, Inc. Miscellaneous Commercial ServicesCommercial Services International Society of Differentiation, Inc. engages in development, research and communication in the fields of cell and developmental biology, molecular biology and oncology. The company was founded by Jean Louis Auguste Brachet in 1971 and is headquartered in St. Paul, MN. | Commercial Services |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
| Princess Maxima Centre For Pediatric Oncology | |
| Hubrecht Organoid Technology Foundation | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Health Technology |
